Sustainability Report 2014 Lek d.d.

Company Profile Sustainability Report 2014 – Lek d.d. 24 26 GRI Disclosures G4-14, G4-15, G4-16, G4-56 1.5.4 Lek’s commitment to external initiatives and principles 26 As a Sandoz company and as a part of the Novartis Group, Lek is committed to implementing a number of initiatives, including the following: • UN Universal Declaration of Human Rights, • ILO Declaration on Fundamental Principles and Rights at Work, • Rio Declaration on Environment and Development, • UN Convention against Corruption, • OECD Guidelines for Multinational Enterprises, • OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, and • voluntary commitment to reduce greenhouse gas emissions in accordance with the Kyoto Protocol. Novartis is a member of the Workplace Wellness Alliance of the World Economic Forum (WEF) ( http://www.wforum.org/ issues/workplace-wellness-alliance ) . Their guidelines were also embraced by Lek, a Sandoz company. At Lek, the development and manufacture of medicinal prod- ucts strictly comply with Pharmacopoeia requirements, WHO and OECD standards; requirements of the FDA and the Public Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), and the Good Labora- tory Practice recommendations. The development of medic- inal products, APIs and manufacturing procedures is based on precautionary measures such as progressivity, inclusion of independent scientists, as well as open and transparent consideration of strengths and weaknesses. Dr Godnov spoke about the treatment of one of the toughest diseases of our time, chronic kidney disease Chronic kidney disease Personal stories and a patient’s vital energy Meeting a doctor, specialist nephrologist, and a kidney disease patient, deeply touched associates at Biopharma- ceuticals Menge‰ Prof. Dr Marko Malovrh, specialist nephrologist, and a chronic kidney disease patient Dr Uro‰ Godnov spoke to the associates at Biopharmaceuticals Menge‰ about the treatment of one of the most difficult diseases of our time, drawing on their own experience. Prof. Dr Malovrh enlightened Lek associates at Menge‰ on the subject of chronic kidney disease, the key risk fac- tors and the course of treatment. Among treatment options mentioned was also erythropoietin, one of the most impor- tant medicines for the treatment of kidney diseases. Uro‰ Godnov, doctor of Information Science, a patient with chronic kidney disease, dancer, cyclist, shared with the audience his personal experience of living with this severe and long-term condition. Despite his difficult diagnosis, Dr Godnov manages to function successfully in his working environment, moreover, he cycles, dances and lives life to the full. His open and moving story as well as his courage and desire to live an active life, deeply touched all asso- ciates gathered in the packed lecture hall. He presented his views on the quality of life with the disease also at the Quality Day event in Lendava.